Search results for Cvs Health

<![CDATA[Pharmaceutical Executive Daily: CVS Health to Offer Zepbound and Foundayo]]>

News 5/8/26

Top News CVS Health reports Q1 results: revenue up 6%, ...

CVS Health debuts apothecary-style pharmacy locations

CVS execs say company on track to meet MA margin goals by 2028

CVS Health beat the Street on both earnings and revenue in Q1, posting $2.9 billion in profit for the quarter.

CVS (CVS) Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. DATEThursday, May 7, 2026 at 8 a.m. ETCALL PARTICIPANTSChair and Chief Executive Officer — J. David JoynerChief Financial Officer — Brian O. NewmanE...

Past is Prologue as CVS Returns to Its “CVS Pharmacy” Roots – What it Means for Health Consumers and Retail Health (with...

Going back to its roots, CVS Health announced plans to open 20 “apothecary-style” pharmacies around the U.S., the first of which was sited in Chicago’s West End.                The...

Here’s What Analysts Are Saying About CVS Health Corporation (CVS)

Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program

CVS Health (CVS) Price Target Boosted by $1

CVS offloads Omnicare pharmacy unit in $250m bankruptcy sale

A private equity-backed buyer steps in as the healthcare giant continues to streamline its sprawling empire

CVS Health opens pharmacy-only locations as it rightsizes store footprint

CVS Health plans to open 20 pharmacy-only locations this year as part of its healthcare-focused strategy.

Huge News for CVS Stock Investors

The healthcare industry breathed a sigh of relief.

CVS to cover Eli Lilly’s anti-obesity pill, reinstate Zepbound later this year

CVS will cover Eli Lilly’s anti-obesity pill next month, reinstate Zepbound later this year, and keep Wegovy access for Caremark members.

CVS Health Just Got a $13 Billion Reprieve. Here's Why the Stock Could Keep Climbing.

CVS remains undervalued compared to peers, even after recent bullish news.

CVS Health: Still Cheap And Signs Of Improvement

<![CDATA[CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo]]>

CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo

The top pharmacy benefit manager in the U.S., CVS Caremark, will restore coverage to obesity products from Eli Lilly, allowing a significant number of patients to gain access to th...

CVS to cover Eli Lilly’s anti-obesity pill, reinstate Zepbound later this year

CVS will cover Eli Lilly’s anti-obesity pill next month, reinstate Zepbound later this year, and keep Wegovy access for Caremark members.

Is CVS Stock an Undervalued Dividend Stock to Buy?

The company received positive news that could make the stock more attractive.

CNCF Welcomes CVS Health as a Platinum Member To Expand Cloud Native Collaboration 

CVS Health strengthens commitment to secure healthcare and modernization efforts further reducing engineering complexity  SAN FRANCISCO, California – May 18, 2026  – The Cloud Nati...

CVS to expand biosimilar formulary adoptions to improve affordability, accessibility

The move to prioritize biosimilars comes as the company seeks to improve affordability, access and value. Changes will be effective July 1.

CVS Health Launches Apothecary-Style Pharmacy Stores

*CVS Health is reimagining what a pharmacy can look like, and the new vision looks a lot less like a convenience store. The drugstore giant announced on March 30 that it plans to o...

Court approves sale of CVS' Omnicare unit to GenieRx Holdings

CVS' Omnicare unit has secured court approval to sell its business to virtual care company GenieRx Holdings, the healthcare giant announced Thursday.

LAWSUIT UPDATE: Investors in CVS Health Corporation (NYSE: CVS) Shares Should Contact the Shareholders Foundation in Con...

A lawsuit is currently pending for certain investors in shares of CVS Health Corporation (NYSE:CVS). Investors in NYSE:CVS shares should contact the Shareholders Foundation at mail...